Abstract Enterohaemorrhagic Escherichia coli (EHEC) O157:H7, the causative agent for haemolytic uraemic syndrome, has become a significant health concern, due to an increasing number of cases. The focus of this project was rapid (<8 h) detection of E. coli O157:H7 from source and finished waters samples, either directly or indirectly, by dovetailing the procedures with existing total coliform procedures. Evaluation of four immunological lateral diffusion assays determined a detection range between 1 × 10 4 and 1 × 10 6 CFU, with the Reveal ® E. coli O157:H7 Test System (Neogen) being the most sensitive for detecting E. coli O157:H7. Evaluation of the BAX ® System for molecular detection determined that as few as 10 CFU could be reproducibly detected. Coupling either of these detection procedures with organism propagation using Tryptic Soy Broth (TSB) enabled sufficient quantities of E. coli O157:H7, such that the Reveal ® and BAX ® detection methods could be used with the 8 h time frame. Examination of matrix effects on the overall procedure indicated little impact on method performance.
Introduction
Enterohaemorrhagic Escherichia coli (EHEC) O157:H7, the causative agent for haemolytic uraemic syndrome (Karmali et al., 1983) , has received a great deal of attention within the medical and public communities. The disease can be life-threatening in the young and the elderly. Numerous outbreaks of human disease have been reported where E. coli O157:H7 transmission occurred following consumption of undercooked meat products, especially ground beef. Transmission by person-to-person, from consumption of contaminated vegetables or unpasteurised apple cider, as well as by the waterborne route, has also led to outbreak situations (Riley et al., 1983; Swerdlow et al., 1992) .
In the United States, E. coli O157:H7 has become a major public health concern, with an estimated 20,000 cases and >250 deaths occurring annually (Boyce et al., 1995) . These increasing incidences of E. coli O157:H7 have created an urgent need for improved epidemiological surveillance, which requires the need for simple, rapid and sensitive isolation and detection procedures. Traditionally, E. coli O157:H7 biochemical characteristics (i.e. inability to ferment sorbitol) have been incorporated into culture procedures using sorbitol-MacConkey agar (March and Ratnam, 1986) , but these approaches are tedious, timeconsuming and, most importantly, lack the specificity for accurate determination.
In our studies, several immunological assays and one molecular assay (BAX) were used to determine the detection sensitivity of E. coli O157:H7. Compatibility of the most promising detection procedures with direct capture by immunomagnetic separation was evaluated to define overall protocols for isolation and detection of E. coli O157 from source and finished water samples. The sensitivity (and reproducibility) of these overall procedures was determined using spiked environmental water matrices (derived from various geographic locations within the US).
Materials and methods

Sensitivity measurements for lateral diffusion assays
The sensitivity of four commercially available immunological lateral diffusion assays was examined at spike doses ranging between 1 × 10 3 -1 × 10 6 CFU per test. The tests evaluated in this study were (a) the ImmunoCard ® STAT! E. coli O157:H7 (Meridian Diagnostics, Inc.), (b) E. coli O157 Antigen Detection Test (Mionix), (c) Eclipse™ E. coli O157:H7 Detection Kit (Eichrom Technologies) and (d) Reveal ® E. coli O157:H7 Test System (Neogen). All assays were performed according to the manufacturer's instructions, and required boiling of the samples for 10 min to generate soluble antigens which were placed as 100 µL aliquots into wells on the lateral diffusion cassettes.
Sensitivity measurements for molecular detection (BAX) assay
The sensitivity of the BAX ® System (DuPont Qualicon, Wilmington, DE) was determined using a single strain of E. coli O157:H7 (ATCC 35150) at spike doses of 0.1-1 × 10 5 CFU. Briefly, lysis reagent was prepared by preparing 1/80 dilution of the protease enzyme in the lysis buffer (both provided in the kit). Lysis reagent (200 µL) was added to each spike dose tested (typical volume 2-5 µL) and samples were incubated at 37°C (30 min) followed by 95°C (10 min). Samples were allowed to cool to room temperature, and 50 µL of each sample lysate was transferred to individual PCR tubes containing BAX ® PCR tablets. Following hydration of the tablets, the PCR tube strips were loaded into the BAX ® cycler/detector. The BAX ® System application contained pre-programmed cycling and detection conditions which were initiated by choosing the appropriate target pathogen (E. coli O157:H7) within the BAX ® System application. Following completion of the cycling and detection program, data output was recorded qualitatively as either positive or negative for the presence of E. coli O157:H7 target DNA sequence.
E. coli O157:H7 growth curves in various media
A comparison of growth dynamics of E. coli O157:H7 (ATCC 35150) in Tryptic Soy Broth (TSB) and several other enrichment media was examined. Preparation of TSB (Becton, Dickinson and Co.), BAX Enrichment (Dupont Qualicon), Reveal Enrichment (Neogen), Medi8 (Eichrom Technologies) and mEC (Becton, Dickinson and Co.) were prepared according to the manufacturers' instructions. For each media type, approximately 100 mL volumes were aseptically transferred into 225 mL Erlenmeyer flasks and inoculated with either 10 or 100 CFU of E. coli O157:H7 (ATCC 35150). Flasks were prepared in duplicate -one for a growth curve at 37°C and one for 42°C. After inoculation, the flasks were placed in the appropriate incubator with shaking. For each medium and temperature condition, sub-samples (5 mL) were removed at various time intervals (between 2 and 24 h) and quantified using the spread plate procedure on TSA. Where necessary, serial dilutions of the sub-samples were analysed to ensure the CFU per plate did not exceed 300.
Matrix effects on overall procedure
The overall method for rapid detection of E. coli O157:H7 would likely begin with a water sample ranging in volume from 50 mL to 200 mL. Working with this volume would not be feasible with other components of the overall method, specifically the propagation-IMS recovery aspect. Therefore, the water samples were concentrated to a suitable working volume using membrane filtration. Briefly, 200 mL samples of MQ water or autoclaved source water from up to seven sites were spiked individually with low numbers (8-20 CFU) of E. coli O157:H7 (ATCC#35150). Each spiked sample was filtered through an individual 0.45 µm mixed cellulose ester filter (MicroFunnel II, Pall Gelman) and the filters eluted with 10 mL TSB. Each eluted sample was transferred to an individual Leighton tube and incubated for 2 h at 42°C. Dynabeads ® (100 µL) of anti-E. coli O157 (Dynal, Inc.) immunomagnetic beads were added to each sample, followed by continued incubation at 42°C for an additional 1 h. Growth control samples (10 mL TSB spiked with 10 CFU) were processed in the same manner, and served to measure the growth potential of the spiked organisms. The samples were subjected to IMS according to manufacturers' instructions and the beads re-suspended in 1 mL PBS. Aliquots (5 × 100 µL) of each sample were spread plated, plates were incubated at 37°C overnight and enumerated the next day. Recovery efficiencies were calculated by comparing the colonies recovered from each matrix to that of the growth controls.
Results
Sensitivity measurements for lateral diffusion assays
The commercially available lateral diffusion format detection procedures were used to examine the detection sensitivity of known numbers of organisms, administered in 100-120 µL volumes (Table 1 ). These data indicated that the ImmunoCard ® STAT test kit required 1 × 10 6 CFU of either of the two strains of E. coli O157:H7 to generate a medium strength positive signal, whereas, with the Eclipse ® test kits, only one strain (ATCC 35150) was examined and generated a signal at the same organism concentration. Both these kits failed to generate a signal when 1 log lower concentrations of E. coli O157:H7 were examined.
In contrast, both the Mionix and Reveal ® test kits yielded strong positive signals when a spike dose of 1 × 10 5 CFU per test of one E. coli O157:H7 isolate (ATCC 35150) was used. Although the Reveal ® test kit continued to yield a weak signal when 1-log lower concentrations of the same E. coli O157:H7 isolate were examined, two of three tests with the Mionix test kit indicated no signal at the same organism concentrations. In one of the three tests with the Mionix kits, no band was observed in the control zone, thus invalidating the test. Using the second E. coli O157:H7 strain (ATCC 43890), approximately 1-log higher concentration of organisms was required to produce a signal of the same intensity as the first E. coli O157:H7 strain (Table 1) for the Reveal ® test kit. During these tests, a weaker than normal control band signal was also generated, suggesting that the poor performance of the kit was a probable reason for the higher detection limit with the second isolate.
Sensitivity measurements for molecular detection (BAX ® ) assay BAX ® System sensitivity was examined using E. coli O157:H7 (ATCC 35150) and spike doses of 0.1-1 × 10 5 CFU (Figure 1) . Results indicated that spike doses of 10 CFU or higher yielded positive BAX ® results 100% (n = 14/14) of the time. Spike doses of 6 CFU or 8 CFU yielded 80% and 65% respectively, whereas spike doses of 2-5 CFU yielded 20-40% positives. To achieve a 100% positive detection rate with the BAX ® system, a minimum of 10 CFU of E. coli O157:H7 was required per BAX ® reaction. Of the various media that were examined for growth dynamics for E. coli O157:H7, TSB yielded the highest growth rate at each of the time intervals examined. Based on the growth dynamics of E. coli O157:H7 in TSB, it appeared that an initial spike dose of 1 CFU/mL rendered sufficient organisms after 3 h enrichment (>100 CFU/mL) to yield a positive signal with the BAX ® assay and 6 h enrichment (>1 × 10 4 CFU/mL) to yield a positive signal with the Reveal ® assay. While the Reveal ® detection procedure only required 30 min for completion, the BAX ® assay required a minimum of 4 h. This indicated that the total time required for enrichment and detection with both assays was less than 8 h.
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Matrix effects on overall procedure when using membrane filtration
Although both MQ water and the various river waters demonstrated wide variability, the data indicated that the overall procedure was effective for recovering low numbers of organisms (Table 2) . Thus far, the lowest recovery from river water has been 29% when using an initial spike dose of 10 CFU. Based on this worst-case scenario, the method sensitivity would be as follows: 10 CFU/200 mL or 0.05 CFU/mL; however, as method recovery was only 29%, it would increase the threshold of method sensitivity approximately three-fold (i.e. to 0.17 CFU/mL). In contrast, using the highest recovery efficiencies (i.e. 156% with a spike dose of 8 CFU), the method sensitivity would be 0.03 CFU/mL. When considering that the typical concentrations of E. coli O157:H7 in environmental samples can range from 0.04 to 0.2 CFU/mL, the overall method reported here would adequately meet the required specifications.
Conclusions
One immunological and one molecular procedure have been identified for rapid detection of E. coli O157:H7 from environmental water samples. These detection procedures were coupled with sample concentration (membrane filtration and immunomagnetic separation) to achieve a rapid procedure for isolation and detection of E. coli O157:H7 from untreated and treated water samples. Current data indicated that the sensitivity (0.03-0.17 CFU/mL) was adequate for environmental screening programmes and method performance was not sensitive to matrix effects. This method was found to be capable of direct analysis of raw/treated water samples and was equally effective for samples that had been processed previously by the presence-absence TC procedures.
